Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon α 2B …
YZ Patt, A Hoque, M Roh, L Ellis… - American journal of …, 1999 - journals.lww.com
The case described here illustrates the antitumor activity of a four-drug systemic combination
chemobiotherapy with platinol, recombinant interferon α 2b, doxorubicin (Adriamycin), and 5-
fluorouracil (5-FU)(PIAF) in a patient with diffuse hepatocellular carcinoma involving the liver
and lungs.
chemobiotherapy with platinol, recombinant interferon α 2b, doxorubicin (Adriamycin), and 5-
fluorouracil (5-FU)(PIAF) in a patient with diffuse hepatocellular carcinoma involving the liver
and lungs.